Meta-Analysis
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Jun 27, 2023; 15(6): 1202-1210
Published online Jun 27, 2023. doi: 10.4240/wjgs.v15.i6.1202
Table 1 Characteristics of the studies


Zhao etal[18]
Tamura etal[19]
Xiao etal[23]
Challine etal[24]
Zhao etal[25]
CountryChinaJapanChinaFranceChina
Published year20212021201120202013
Study designRCTRCTRCTPCSPCS
Study settingMulticenterMulticenterSingle centerSingle centerSinglecenter
AgeTDT62 (54-69)169 (40-90)159 ± 11264 ± 122≥ 60/< 60, 30/51
Non-TDT62 (52-69)169 (39-91)158 ± 12260 ± 122≥ 60/< 60, 36/41
Sex (male/female)TDT177/10351/28115/8551/2147/34
Non-TDT169/11150/28121/7751 / 2143/34
Preoperative treatment (radiochemotherapy)TDTExcluded10 (12.7%)Excluded41 (56.9%)Excluded
Non-TDTExcluded19 (24.3%)Excluded47 (65.3%)Excluded
DSTDT72 (25.7%)34 (43.0%)ExcludedUnknown but equal rate by matchingExcluded
Non-TDT89 (31.8%)37 (47.4%)ExcludedUnknown but equal rate by matchingExcluded
Type of tubeSilicone tube, 28 FrLatex tube, 20-24 FrSilicone tube commonly used for abdominal drainageFoley catheter, Ch 22Rubber tube, 26 Fr
Duration3-7 dAt least 5 d5-7 dAt least 4 d5-6 d
Significant side effects relating to anal tubeAnal painNonePerianastomotic bleedingNoneNone
AL (A/B/C)TDTNA/14/42/5/1NA/6/212/9/4NA/0/2
Non-TDTNA/11/83/7/1NA/3/169/5/2NA/0/7
AL in the patients wihout a DS (A/B/C)TDTNA/8/4NANA/6/2NANA/0/2
Non-TDTNA/7/8NANA/3/16NANA/0/7